hepatitis-c-virus
Hepatitis C

New Hepatitis C Infections Have Tripled over The Past Five Years

Editor’s Note: Hepatitis C is a potentially deadly viral infection, and the majority of deaths occur in people 55 and older. A simple hepatitis C test can tell whether you have contracted it. Risk factors include: receiving a blood transfusion before 1992; sharing needles or getting a tattoo in unsanitary conditions; and having multiple sexual partners or sexual contact with a person infected with hepatitis C. The risk is greater if you have had multiple sexual partners. (For more on risk factors, click here.) From the federal Centers for Disease Control and Prevention (CDC), here is an update on this condition and its increasingly common presence in the U.S.:

Over just five years, the number of new hepatitis C virus infections reported to the CDC nearly tripled, reaching a 15-year high, according to new preliminary surveillance data released by the CDC in a news release.

The news release pointed out that because hepatitis C has few symptoms, nearly half of people living with the virus don’t know they are infected and most new infections go undiagnosed. Further, limited surveillance resources have led to underreporting, meaning the annual number of hepatitis C virus cases reported to CDC (850 cases in 2010 and 2,436 cases in 2015) does not reflect the true scale of the epidemic.

CDC estimates about 34,000 new hepatitis C infections actually occurred in the U.S. in 2015.

Hepatitis C kills more Americans than any other infectious disease reported to CDC. These latest statistics also indicate that nearly 20,000 Americans died from hepatitis C-related causes in 2015, and the majority of deaths were people ages 55 and older.

“By testing, curing, and preventing hepatitis C, we can protect generations of Americans from needless suffering and death,” said Jonathan Mermin, M.D., director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

“We must reach the hardest-hit communities with a range of prevention and treatment services that can diagnose people with hepatitis C and link them to treatment. This wide range of services can also prevent the misuse of prescription drugs and ultimately stop drug use – which can also prevent others from getting hepatitis C in the first place.”

New hepatitis C virus infections are increasing most rapidly among young people, with the highest overall number of new infections among 20- to 29-year-olds. This is primarily a result of increasing injection drug use associated with America’s growing opioid epidemic.

However, the majority (three-quarters) of the 3.5 million Americans already living with hepatitis C are baby boomers born from 1945 to 1965. Baby boomers are six times more likely to be infected with hepatitis C than those in other age groups and are at much greater risk of death from the virus.

While surveillance data do not accurately capture hepatitis C infection rates among infants, other recent CDC studies indicate that hepatitis C virus infections are growing among women of childbearing age – putting the youngest generation of Americans at risk. Hepatitis C treatment not only cures the vast majority of people living with the virus, but also prevents transmission to their partners and children, CDC says.

In its news release, the CDC said that comprehensive approaches are needed to combat the dual epidemics of opioid addiction and injection-related infectious diseases. The U.S. Department of Health and Human Services (HHS) has brought five specific strategies to fight against the opioid epidemic that will save lives and reduce the impact of injection-related infectious diseases. These are: improving access to treatment and recovery services, promoting use of overdose-reversing drugs, strengthening our understanding of the opioid epidemic through better public health surveillance, providing support for cutting-edge research on pain and addiction, and advancing better practices for pain management. Comprehensive syringe service programs (SSPs) are one of many tools that communities can use to prevent hepatitis and other injection-related infectious diseases. These programs also help link people to treatments to stop drug use, testing for infectious diseases that can be spread to others, and medical care.

While new medicines can now cure hepatitis C virus infections in as little as two to three months, many people in need of treatment are still not able to get it. HHS recently released the National Viral Hepatitis Action Plan, 2017-2020 that sets goals for improving prevention, care, and treatment of viral hepatitis and puts the nation on a course toward eliminating new hepatitis infections. The importance of this effort was underscored by the National Academies of Sciences, Engineering and Medicine, which in a recent report concluded that eliminating hepatitis C as a public health threat in the United States is feasible if the right steps are taken.

“Stopping hepatitis C will eliminate an enormous disease and economic burden for all Americans,” said John Ward, M.D., director of CDC’s Division of Viral Hepatitis. “We have a cure for this disease and the tools to prevent new infections. Now we need a substantial, focused, and concerted national effort to implement the National Viral Hepatitis Action Plan and make effective prevention tools and curative treatment available to Americans in need.”